Effectiveness of needle-exchange programmes for prevention of HIV infection

Lancet

Volumn 349, Issue 9068, 1997, Pages 1797-1800

  Hurley, Susan F ^b   Jolley, Damien J ^c   Kaldor, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CSL LIMITED   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECOLOGY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; NEEDLE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES;

EID: 0030994136     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)11380-5     Document Type: Article

References (14)

1. Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992; 6: 1053-68.
2. Centers for Disease Control and Prevention. AIDS associated with injecting-drug use - United States, 1995. MMWR Morb Mortal Wkly Rep 1996; 45: 392-97.
3. Stimson GV. Syringe-exchange programmes for injecting drug users. AIDS 1989; 3: 253-60.
4. Panel on Needle Exchange and Bleach Distribution Programs. Preventing HIV transmission: the role of sterile needles and bleach. Washington: National Academy Press, 1995.
5. Institute for Health Policy Studies. The public health impact of needle exchange programs in the United States and abroad. Berkeley: School of Public Health, University of California, 1993.
6. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1995; 85: 1531-37.
7. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348: 987-91.
8. US General Accounting Office. Needle exchange programs: research suggests promise as an AIDS prevention strategy. Washington, DC: US Government Printing Office, 1993.
9. Prevots DR, Allen DM, Lehman S, Green TA, Peterson, LR, Gwinn M. Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. Am J Epidemiol 1996; 143: 733-42.
10. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press, 1993.
11. Nicolosi A, Leite ML, Musicco M, Molinari S. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Northern Italian Seronegative Drug Addicts (NISDA) Study. Am J Epidemiol 1992; 135: 225-33.
12. Kaplan EH, Heimer R. A circulation theory of needle exchange. AIDS 1994; 8: 567-74.
13. Des Jarlais DC, Hagan H, Friedman S, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995; 274: 1226-31.
14. Kaplan EH. A method for evaluating needle exchange programmes. Stat Med 1994; 13: 2179-87.